Hyperfine, Inc. Reports Strong Q3 Growth Amid Losses

Hyperfine Inc. ( (HYPR) ) has released its Q3 earnings. Here is a breakdown of the information Hyperfine Inc. presented to its investors.

Hyperfine, Inc. is a health technology company that has revolutionized brain imaging with its FDA-cleared AI-powered portable MR imaging system, the Swoop® system, primarily serving the healthcare sector. In its third-quarter 2025 financial report, Hyperfine, Inc. highlighted the successful launch of its next-generation Swoop® system and Optive AI software, marking significant strides in expanding its market presence, particularly in neurology offices. The company reported a 27% increase in revenue from the previous quarter, reaching $3.4 million, and achieved a record gross margin of 53.8%. Despite these gains, Hyperfine faced a net loss of $11 million, attributed in part to increased sales, marketing, and administrative expenses. Looking ahead, Hyperfine’s management anticipates a strong fourth quarter with expected revenues between $5 to $6 million, reflecting substantial growth both sequentially and year-over-year, while also projecting a reduced cash burn for the full year 2025.